	Sentinel Surveillance of Influenza A in Libya: Subtyping and Genomic Analysis During Recent Seasons (2022-2024). Trop Med Infect Dis Azbida M, Ferjani S, Elahmer O, Osman R, Shenaisheh S, Barakat A, Abid S, Eljerbi A, Kammon A, Sallemi A, El-Saeh H, Boutiba-Ben Boubaker I, Eldaghayes I. PMID: 42188856 [PubMed]
	Bacterial Membrane Vesicles as Versatile Platforms for Systemic and Mucosal Vaccines. Vaccines (Basel) Park SH, Son YM. PMID: 42188810 [PubMed]
	Mucosal Delivery of Recombinant SARS-CoV-2 Spike Receptor-Binding Domain Antigen Containing Immune-Stimulating Peptides Induces Protective Immune Responses Against Viral Infection in huACE2 Mice. Vaccines (Basel) Cho BH, Kim J, Jang YS. PMID: 42188793 [PubMed]
	Intranasal Immunization with Live-Attenuated RSV-Vectored SARS-CoV-2 Vaccines Elicits Antigen-Specific Systemic and Mucosal Immunity and Protects Against Viral Challenge and Natural Infection. Vaccines (Basel) Botta D, Schultz MD, Silva-Sanchez A, Kalange D, Akther J, Zhou F, Tipper JL, Yang G, Schaefers LT, Barkley CA, Qiu S, Foote JB, Tioni MF, Weiss CM, Phan SI, Green TJ, Leal SM Jr, Harrod KS, King RG, Moore ML, Randall TD, Tang RS, Lund FE. PMID: 42188772 [PubMed]
	Measuring Humoral Immune Responses to SARS-CoV-2: A Comprehensive Review of Serological Assays. Vaccines (Basel) Xue H, Haynesworth K, Hempel HA, Kemp TJ, Pinto LA. PMID: 42188768 [PubMed]
	Hybrid and Vaccine-Induced Immunity Against SARS-CoV-2 in a Cohort of Hospitalized Patients from the Metropolitan AburrÃ¡ Valley, Colombia. Vaccines (Basel) Hernández-Ortiz OH, Naranjo AF, Vélez-Cadavid JJ, De La Rosa G, Gil BA, Moreno AM, Perez-Restrepo LS, Usuga J, Aristizabal-Valencia M, Molina-Saldarriaga F, Sará-Ochoa JE, Betancourt-Rodriguez N, Jaimes F, Osorio JE, Hernández-Ortiz JP. PMID: 42188767 [PubMed]
	Poria cocos Polysaccharide Fraction PCP-II Enhances Humoral and Cellular Responses to a SARS-CoV-2 RBD Subunit Vaccine in Mice. Vaccines (Basel) Zhou M, Liu J, Zhang X, Yan F, Wu Y, Huang C, Xie D, Liu B. PMID: 42188762 [PubMed]
	COVID-19 Vaccine Effectiveness in Individuals with Alcohol and Tobacco Use Disorders: A Propensity Score-Matched Study Using Nationwide Brazilian Data. Vaccines (Basel) Oliveira FES, Martelli DRB, Oliveira MCL, Colosimo EA, Simões E Silva AC, Andrade ALO, Herrerias RR, Foligno LRC, Barbosa IO, Martelli-Junior H, Oliveira EA. PMID: 42188749 [PubMed]
	Humoral and Cellular Immune Response in Patients with Hematological Disorders After Three Doses of mRNA COVID-19 Vaccine: A Single-Center Observational Study. Vaccines (Basel) Daffini R, Zecchini F, Venneri G, Malagola M, Cattaneo C, Calza S, Caruso A, Tucci A, Giagulli C. PMID: 42188741 [PubMed]
	Marine Natural Products as Potent Anticancer Agents (2020-2024): Structural Diversity, SARs and Target Prediction. Mar Drugs Huang Z, Du Y, Hu J, Ying L, Zhou B, Hua Y, Wang H, Yang Z. PMID: 42188308 [PubMed - indexed for MEDLINE]
	Marine Polysaccharides Modulating the Gut Microbiota-Immune Axis in Digestive Tract Tumors: An Update. Mar Drugs Wang L, Gao D, Chen X, Chen Y. PMID: 42188283 [PubMed - indexed for MEDLINE]
	Clinical Course and Perinatal Outcomes of Pregnant Women with COVID-19 in Central Greece: A Prospective Cohort Study. Diseases Donoudis C, Garas A, Sotiriou S, Pantazopoulos I, Pagonis A, Zachari E, Daponte N, Syrogiannopoulos G, Grivea I, Daponte A. PMID: 42187890 [PubMed]
	Exploring Spike-Dependent and ACE2-Independent SARS-CoV-2 Interactions with Salivary Epithelial Cells in the Absence of ACE2. Biology (Basel) Barrows CML, Geremias TC, Young S, Farach-Carson MC. PMID: 42187740 [PubMed]
	Cell-Based Luciferase Assay for Testing SARS-CoV-2 3CL Protease Inhibitors. Biosensors (Basel) Shcherbakov DN, Mordvinova ED, Trufanov VO, Volkova NV, Meshkova YV, Marenina MK, Zaykovskaya AV, Volosnikova EA, Borisevich SS, Belenkaya SV. PMID: 42187449 [PubMed - indexed for MEDLINE]
	Innate Immune Mechanisms Triggered by SARS-CoV-2 Virus-Like Particles: Role of Antibody Opsonization. ACS Appl Bio Mater Lu, Usvaltas M, Maciulis V, Plikusiene I. PMID: 42187064 [PubMed - as supplied by publisher]
	From weak but broad to potent and universal: A trispecific antibody against conserved SARS-CoV-2 spike epitopes. Mol Ther Tian X, Wang C, Han P, Liu H, Wu L, Wang X, Yu S, Zhang Y, Zhao B, Liu J, Gao GF, Wang Q. PMID: 42186224 [PubMed - as supplied by publisher]
	Trajectories and Risk Factors of Poor Physical and Mental Health Among Cancer Survivors Before, During, and After the COVID-19 Pandemic. Psychooncology Alizai Q, Mevawalla A, Angez M, Ejaz R, Elemosho A, Ekenze S, Yuza K, Bega R, Pawlik TM. PMID: 42186117 [PubMed - indexed for MEDLINE]
	Relationship between negative-pressure ICU rooms and the risk of COVID-19-associated pulmonary aspergillosis: an ancillary analysis of the COVID-ICU cohort study. Crit Care Kreitmann L, Rouzé A, Luyt CE, Razazi K, Fartoukh M, Bruneel F, Gouzien L, Maxime V, Le Terrier C, Zahar JR, Béhal H, Nseir S, COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. PMID: 42186034 [PubMed - as supplied by publisher]
	Epigenetic ageing during the COVID-19 pandemic: global age acceleration, independent of SARS-CoV-2 infection. Clin Epigenetics Shore CJ, Österdahl MF, Harvey NR, Zhao N, Kristiansen M, Michaud DS, Steves CJ, Bell JT, Duncan EL. PMID: 42185922 [PubMed - indexed for MEDLINE]
	Standardizing antiviral response metrics for mono- and combination therapies in acute, chronic and latent viral infections. Virol J Petakh P, Ravlo E, Pan Q, Bruzzone R, Oksenych V, Vähä-Koskela M, Kamyshnyi O, Kainov DE. PMID: 42185895 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 288233

Page 1 of 14412



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy